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Summary.-The influence of two prostaglandin (PG) analogues, 16,16-dimethyl
PG E2 and 16,16-dimethyl PG F2, and of the cyclo-oxygenase inhibitor, flurbiprofen,
on epithelial cell proliferation was assessed using a stathmokinetic technique. The
epithelia examined were those of the jejunal crypts, the colonic crypts and that of
dimethylhydrazine-induced adenocarcinomas of rat colon. The influence of the two
prostaglandin analogues, and of flurbiprofen, oi the growth of a human colorectal
tumour propagated as xenografts in immune-deprived mice was also assessed.
The PG E2 analogue transiently inhibited xenograft growth, but was without effect
on the mitotic rate in the rat tissues. The PG F2<x analogue was also found to inhibit
xenograft growth but, unlike the PG E2 analogue, it was found to be a strong inhibitor
of cell proliferation in rat colonic tumours, and an accelerator of proliferation in
jejunal-crypt cells. The only statistically significant effect of flurbiprofen was to
accelerate cell division in the rat colonic tumours.
A WIDE VARIETY of systemic hormones,
local hormones and neurotransmitter sub-
stances have now been shown to influence
the rate of cell proliferation in epithelium
of the jejunal crypt, the colonic crypt
and dimethylhydrazine (DMH)-induced
colonic adenocarcinomas of rat colon (for
reviews, see Tutton, 1977, and Tutton &
Barkla, 1979a). Some of the agents that
have been shown to influence cell division
in primary rat colonic tumours have now
been shown to have a similar influence on
human colonic tumours propagated as
xenografts in immune-deprived mice (Tut-
ton & Steel, 1979). However, the response
to a particular agent varies markedly
between each of the tissues examined.
For example, o-adrenoceptor agonists pro-
mote cell division in thejejunal and colonic
epithelium but not in colonic adenocar-
cinomas (Tutton & Helme, 1974; Tutton
& Barkla, 1977), whereas histamine and
serotonin promote cell division in the
jejunal crypts (Tutton, 1974, 1976) and in
colonic tumours, but not in colonic crypts
(Tutton & Barkla, 1978a, b). The present
report concerns the possible growth-
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regulating properties oftwo prostaglandin
analogues, 16,16-dimethyl PG E2 and
16,16-dimethyl PG F2,.
MATERIALS AND METHODS
Induction of rat colonic tumours.-Male
Sprague-Dawley rats were fed Clark King
Nu-pig pellets and tap water ad libitum and
housed at 21-24TC with artificial light from
07:00 to 21:00 and darkness from 21:00
to 07:00. Rats were given weekly s.c. injec-
tions of 1,2-dimethylhydrazine (DMH;
Aldrich Chemical Company, Milwaukee, Wis-
consin) at a dose of 21 mg/kg, as previously
described (Druckrey et al., 1967; Tutton &
Barkla, 1976). After 21 weeks the DMH
injections were discontinued and, after an
interval of 2-8 weeks, the animals were used
in the experiments described below.
Estimation of mitotic rates.-All rats were
injected with vinblastine sulphate (Velbe, Eli
Lilly Co.) 4 mg/kg at 12:00 and killed by
decapitation at times ranging from 12:45 to
16:00. Counts of metaphase and non-meta-
phase cells in jejunal crypts, colonic crypts
and colonic adenocarcinomas were made at
1250 x magnification, and metaphase indices
were calculated and corrected for sectioningP. J. M. TUTTON AND D. H. BARKLA
and geometric artefacts, as previously des-
cribed (Tutton & Barkla, 1976).
Graphs oftrue metaphase index vs duration
of vinblastine treatment were then construc-
tedforeachexperimentalgroupoftissueswith
mitoses blocked for 0 75-4 0 h. The regression
coefficient for each of the graphs was then
calculated by the method of least squares;
this calculated value represents the rate at
which cells entermetaphase, andhas the units
of mitoses/cell/h. The statistical significance
of differences between the regression co-
efficients for different experimental groups of
tissue was estimated by analysis of variance
(Bliss, 1967).
Initially, cell proliferation was studied in
the jejunal crypts of 18 normal rats, the
colonic crypts of 14 normal rats and 5 DMH-
induced adenocarconomas. Cell proliferation
was also studied in 6 normal and 6 DMH-
treated rats injected with either 16,16-
dimethyl PG E2 methyl ester (at doses of
0-025-250 ,tg/kg), 16,16-dimethyl PG F2,
methyl ester (at doses of 0-025-250 ,tg/kg) or
flurbiprofen (1 mg/kg). Flurbiprofen (2-(2-
fluoro-4-biphenylyl) propionic acid) is a
potent cyclo-oxygenase (previously referred
to as prostaglandin synthetase) inhibitor
(Crook & Collins, 1975). PG analogues were
dissolved in absolute ethanol at a concentra-
tion of 10 mg/ml and stored at -30°C. Before
injection they were diluted with normal saline
to give an injection volume of 0-2 ml. Flur-
biprofen was dissolved in normal saline at a
concentration of 0 1 mg/ml. Rats received a
single injection of each drug at 12:00. Be-
cause PG F2a has been shown to increase
noradrenaline output from some sympathetic
nerve terminals (Kadowitz et al., 1972) and
noradrenaline increased the mitotic rate in
jejunal crypts (Tutton & Helme, 1974), the
influence of 16,16-dimethyl PG F2a was also
assessed in chemically sympathectomized
rats. Twelve animals were injected i.v. with
6-hydroxydopamine at a dose of 100 mg/kg,
and 5 days later jejunal-crypt cell mitotic
rates were measured with an without 16,16-
dimethyl PG F2a. 6-Hydroxydopamine has
previously been shown to cause destruction
ofsympathetic nerve terminals in ratjejunum
(Tutton & Helme, 1974). 6-Hydroxydopamine
was dissolved at a concentration of100 mg/ml
in distilled water containing sodium ascorbate
at a concentration of 1 mg/ml.
Xenograft technique.-Female CBA/lac mice
were immunosuppressed by the technique of
Steel et al. (1978). This involves thymectomy
followed 2 weeks later by injection ofcytosine
arabinoside (Cytosar, Upjohn) at a dose of
200 mg/kg and, after a further 24 h, the
administration of 9 Gy of whole-body
irradiation. Pre-treatment with cytosine ara-
binoside obviates the need for marrow recon-
struction after irradiation. Small fragments
(2-3 mm in greatest linear dimension) of
tumour HXK4 (Nowak et al., 1978) were
implanted s.c. in each flank of the mice.
Tumour HXK4 was originally propagated
from a moderately differentiated carcinoma
of the rectosigmoid junction.
From the 20th day after implantation,
tumours were measured every 1-2 days. The
largest and smallest superficial diameters
were recorded and the tumour volume was
calculated as (mean diameter)317/6. The daily
volume of each tumour (Vt) was divided by
the volume of that tumour on the first day of
measurement (Vo) to obtain the relative
tumour volume. The mean and standard
error of this quotient was then plotted as a
function of time after the first measurement
for each group of tumours. The relative
volume was calculated because inter-tumour
variation in this parameter arises only during
the period of measurement. The control
group consisted of 50 xenografts, and each
experimental group consisted of 10. Each
group was measured for 5 days and the statis-
tical significance of differences between the
relative volumes of various groups of xeno-
grafts was assessed using the Mann-Whitney
non-parametric test for ranked observations
(Sokal & Rohlf, 1969). Experimental groups
of mice were injected every 12 h with either
16,16-dimethyl PG E2 methyl ester (250
,ug/kg), 16,16-dimethyl PG F2, methyl ester
(250 jug/kg) or flurbiprofen (1 mg/kg).
RESULTS
Mitotic rate in rat
The doses of PG analogues and flurbi-
profen were generally well tolerated by
the rats, although all PG-treated animals
developed mild diarrhoea. In the flurbi-
profen-treated animals, there was no
microscopical or histological evidence of
mucosal ulceration during the 4 h period
of the experiment. In the jejunal crypt
epithelial cell proliferation was accelerated
by 16,16-dimethyl PG F20, at each dose
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TABLE.-Mitotic rate
Treatment
Nil (Control)
16,16-dimethylvPG E2
16,16-dimethyl PG F2,
in jejunal crypts, colonic crypts and in DMH-induced
adenocarcinomas
Mitotic rate: mitoses/cell/h (mean + s.e.)
'
Dose/kg Jejunal crypts
0035 + 0-002
250 ,ug 0 044 + 0 009
2-5 /g
0-025 jg
250 Hg
25 ,ug
0-025 ,ug
6-lhydroxydopamine 100 mg
16,16-dimethyl PG F2x
after 6-hydroxydopamine 250 pg
Flurbiprofen I mg
0-081* + 0-016
0.073* + 0005
0.051*+ 0003
0.009* + 0001
0-0801 + 0-019
0-039 + 0.010
Colonic crypts
0-028 + 0-004
0-021 + 0-008
0017 + 0008
0 034 + 0-014
Adenocarcinomas
0-025 + 0007
0-018 + 0-002
0033 + 0-008
0-022 + 0-001
Ot + 0.001
t +± 0-008
0-015 + 0-006
0-068* + 0-015
* Significantly (lifferent (P < 0 05) from control value for corresponding tissue.
t Regression coefficient for mitotic index versus duration of vinblastine treatmentv was
negative and significantly lower (P < 0-05) than control value.
I Significantly higlher (P < 001) than for the corresponding tisstue tieatedl witlh 6-hydroxy-
(lopamine alone.
tested, in both intact and in chemically
sympathectomized rats. The log-dose res-
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FNIe. Graph of log relative tumour volume
'ns time after start of treatme3nt. Each point
represents the mean of at least 10 xeno-
grafts. Bars represent s.e. * Inclicate points
significantly lower (P < 005) than control
xenografts. CSontrol . .......;Flurbiprofen
-; 16,16-dimethlyl PG E2-; l16,1l6-
1imetliyl PF F2a
ponse was linear with a correlation co-
efficient of + 097. Neither 16,16-dimethyl
PG E2 nor flurbiprofen had any statistic-
ally significant influence on jejunal-crypt
cell proliferation.
In the colonic-crypt epithelium none
of the agents significantly influenced cell
proliferation. However, in colonic adeno-
carcinomas, 16,16-dimethyl PG F2c,
strongly inhibited cell proliferation at
doses of250 and 2-5 [kg/kg and flurbiprofen
accelerated it. The log-dose response had
a correlation coefficient of - 090. Again
16,16-dimethyl PG E2 was without sig-
nificant effect. These results are quantita-
ted in the Table.
Xenograft studies
Both 16,16-dimethyl PG E2 and 16,16-
dimethyl PG F2a, inhibited xenograft
growth (P < 0 05) but the effect of the
PG F2c, analogue was more prolonged than
that of the PG E2 analogue. Flurbiprofen
had no statistically significant effect on
xenograft growth (0.2 >P> 01). These
results are illustrated in the Fig.
DISCUSSION
It is clear from the foregoing results
that the PG F2a analogue, 16,16-dimethyl
PG F2x methyl ester, is able to influence
cell proliferation although, as with numer-
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ous other agents, the response varies
markedly from tissue to tissue. It is not
possible from the present experiments to
determine whether the PG analogues are
acting directly on the proliferating cells or
indirectly through, for example, changes in
blood supply, intestinal motility or mast-
cell activity.
PG F2, has been shown to act, in some
cases at least, by raising intracellular
levels of cyclic guanosine monophosphate
(cGMP) (Kuehl et al., 1973) and 3 other
agents that have been shown to stimulate
the formation of cGMP, namely nor-
adrenaline (Schultz et al., 1975), acetyl-
choline (Goldberg et al., 1973) and sero-
tonin (Goldberg et al., 1974), as well as
dibutyryl cGMP itself, have been shown
to accelerate jejunal-crypt cell prolifera-
tion (Tutton & Helme, 1974; Tutton,
1974, 1977; Tutton & Barkla, 1979b).
However, in the case of colonic adeno-
carcinoma, whilst both serotonin (Tutton
& Barkla, 1978b) and dibutyryl cGMP
(Tutton & Barkla, 1979b) promote cell
division, the PGF2, analogue inhibits both
cell division and xenograft growth.
PG E2 has been shown to elevate the
intracellular levels of cyclic adenosine
monophosphate (cAMP) (Kuehl et al.,
1970) and the transient inhibition of
xenograft growth in animals treated with
the PG E2 analogue resembles the in-
fluences of adrenaline, also known to raise
cellular cAMP levels (Sutherland & Rall,
1960) on the tumour HXK4 in xenograft
(Tutton & Steel, 1979). The influence of
adrenaline was prolonged by theophylline,
an agent known to inhibit the enzyme
phosphodiesterase, which degrades cAMP.
When interpreting the apparent incon-
sistency between the influence of injected
prostaglandin analogues (significantly
altering cell proliferation and tumour
growth) and flurbiprofen (having no effect)
on the jejunal crypts and on xenografts,
it must be remembered that inhibition of
cyclo-oxygenase by flurbiprofen will inter-
fere with the production of thromboxanes
and prostacyclin (Johnson et al., 1976) as
well as PG E2 and PG F20,. Alternatively,
flurbiprofen may be ineffective as a cyclo-
oxygenase inhibitor in the intestinal
epithelium. It is difficult to investigate the
influence of thromboxane A2 and prosta-
cyclin on cell division, because each of
these substances is very unstable.
Various prostaglandins and their syn-
thetic analogues have been shown to
influence cell proliferation in other neo-
plastic and non-neoplastic tissues. Kurland
& Moore (1977) reported stimulation of
haemopoietic stem cells by PG E2, whilst
inhibition of cell proliferation in such
tumours as B16 melanoma (Santoro et al.,
1977) and plasmacytoma (Naseem &
Hollander, 1973) has also been reported.
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